Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 19.8M | 21.5M | 23.6M | 22.1M | 20.4M | -- |
| Operating Revenue | 19.8M | 21.5M | 23.6M | 22.1M | 20.4M | -- |
| Cost Of Revenue | 12.9M | 12.3M | 12.7M | 13.4M | 12.8M | -- |
| Gross Profit | 6.9M | 9.2M | 11.0M | 8.7M | 7.6M | -- |
| Selling General And Administration | 1.3M | 1.2M | 1.6M | 2.2M | 1.6M | -- |
| General And Administrative Expense | 1.3M | 1.2M | 1.6M | 2.2M | 1.6M | -- |
| Other Operating Expenses | 7.3M | 6.9M | 7.1M | 6.4M | 6.7M | -- |
| Operating Expense | 8.6M | 8.1M | 8.7M | 8.7M | 8.3M | -- |
| Operating Income | -1.8M | 1.2M | 2.3M | 57,000 | -730,000 | -- |
| EBIT | -2.1M | 14.7M | -2.8M | -4.3M | 8.6M | -- |
| Interest Expense | 1.5M | 1.3M | 1.2M | 1.4M | 1.5M | -- |
| Interest Expense Non Operating | 1.5M | 1.3M | 1.2M | 1.4M | 1.5M | -- |
| Net Interest Income | -1.7M | -1.6M | -1.4M | -1.6M | -1.8M | -- |
| Other Income Expense | -57,000 | 13.7M | -4.8M | -4.1M | 9.6M | -- |
| Other Non Operating Income Expenses | -24,000 | 6,000 | 17,000 | 250,000 | -139,000 | -- |
| Gain On Sale Of Security | -33,000 | 13.7M | -4.8M | -3.9M | 9.8M | -- |
| Pretax Income | -3.5M | 13.4M | -4.0M | -5.7M | 7.1M | -- |
| Tax Provision | -842,000 | 3.0M | -880,000 | -1.7M | 1.8M | -- |
| Tax Effect Of Unusual Items | -7,896 | 3.1M | -1.1M | -1.3M | 2.5M | -- |
| Net Income From Continuing And Discontinued Operation | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Income Including Noncontrolling Interests | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Income Common Stockholders | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Income | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| EBITDA | 9.3M | 24.9M | 7.2M | 5.9M | 18.9M | -- |
| Normalized EBITDA | 9.4M | 11.2M | 12.0M | 10.2M | 9.1M | -- |
| Reconciled Depreciation | 11.4M | 10.2M | 10.0M | 10.1M | 10.2M | -- |
| Basic EPS | -0.02 | 0.08 | -0.02 | -- | 0.04 | 0.02 |
| Diluted EPS | -0.02 | 0.08 | -0.02 | -- | 0.04 | 0.02 |
| Basic Average Shares | 130.3M | 128.3M | 126.0M | -- | 124.4M | 124.3M |
| Diluted Average Shares | 130.3M | 130.7M | 126.0M | -- | 126.7M | 126.6M |
| Total Unusual Items | -33,000 | 13.7M | -4.8M | -4.3M | 9.8M | -- |
| Total Unusual Items Excluding Goodwill | -33,000 | 13.7M | -4.8M | -4.3M | 9.8M | -- |
| Tax Rate For Calcs | 0.24 | 0.22 | 0.22 | 0.29 | 0.26 | -- |
| Normalized Income | -2.7M | -281,778 | 645,927 | -936,579 | -2.0M | -- |
| Diluted NI Availto Com Stockholders | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Income Continuous Operations | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Non Operating Interest Income Expense | -1.7M | -1.6M | -1.4M | -1.6M | -1.8M | -- |
| Other Gand A | 953,000 | 797,000 | 1.1M | -2.4M | 1.2M | -- |
| Reconciled Cost Of Revenue | 12.9M | 12.3M | 12.7M | 13.4M | 12.8M | -- |
| Salaries And Wages | 340,000 | 383,000 | 489,000 | 4.6M | 389,000 | -- |
| Total Expenses | 21.6M | 20.3M | 21.4M | 22.0M | 21.2M | -- |
| Total Other Finance Cost | 260,000 | 252,000 | 231,000 | 261,000 | 270,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 19,000 | 40,000 | 181,000 | 68,000 | 40,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 19,000 | 40,000 | 181,000 | 68,000 | 40,000 | -- |
| Cash Financial | 19,000 | 40,000 | 181,000 | 68,000 | 40,000 | -- |
| Accounts Receivable | 9.0M | 11.7M | 12.5M | 11.6M | 8.5M | -- |
| Receivables | 9.0M | 11.7M | 12.5M | 11.6M | 8.5M | -- |
| Inventory | 324,000 | 445,000 | 486,000 | 590,000 | 788,000 | -- |
| Prepaid Assets | 2.9M | 3.2M | 2.6M | 2.7M | 3.3M | -- |
| Current Assets | 17.4M | 23.5M | 15.8M | 17.6M | 20.3M | -- |
| Gross PPE | 1.2B | 1.1B | 1.1B | 1.1B | 1.1B | -- |
| Accumulated Depreciation | -764.9M | -753.6M | -744.7M | -734.8M | -724.6M | -- |
| Net PPE | 387.9M | 391.1M | 390.5M | 381.7M | 380.4M | -- |
| Total Non Current Assets | 407.5M | 410.5M | 412.2M | 402.5M | 400.9M | -- |
| Total Assets | 424.9M | 434.0M | 428.0M | 420.1M | 421.2M | -- |
| Current Debt | 40.2M | 38.6M | 31.4M | 32.7M | 35.3M | -- |
| Current Debt And Capital Lease Obligation | 40.4M | 38.7M | 31.5M | 32.9M | 35.5M | -- |
| Accounts Payable | 11.9M | 19.9M | 25.4M | 17.3M | 12.7M | -- |
| Payables | 11.9M | 19.9M | 25.4M | 17.3M | 12.7M | -- |
| Payables And Accrued Expenses | 11.9M | 19.9M | 25.4M | 17.3M | 12.7M | -- |
| Other Current Liabilities | 44,000 | -- | 1.8M | -- | -- | 15,000 |
| Current Liabilities | 53.9M | 59.3M | 59.8M | 51.3M | 48.5M | -- |
| Long Term Debt | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | -- |
| Long Term Debt And Capital Lease Obligation | 25.7M | 25.8M | 25.7M | 25.8M | 25.8M | -- |
| Long Term Capital Lease Obligation | 720,000 | 763,000 | 725,000 | 829,000 | 829,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 64.6M | 64.8M | 68.2M | 65.5M | 62.9M | -- |
| Total Liabilities Net Minority Interest | 118.5M | 124.1M | 128.0M | 116.7M | 111.3M | -- |
| Common Stock | 500.7M | 497.8M | 494.9M | 491.9M | 491.1M | -- |
| Capital Stock | 500.7M | 497.8M | 494.9M | 491.9M | 491.1M | -- |
| Additional Paid In Capital | 36.5M | 36.2M | 35.7M | 35.3M | 34.8M | -- |
| Retained Earnings | -230.7M | -224.2M | -230.7M | -223.8M | -216.1M | -- |
| Common Stock Equity | 306.5M | 309.8M | 300.0M | 303.4M | 309.9M | -- |
| Stockholders Equity | 306.5M | 309.8M | 300.0M | 303.4M | 309.9M | -- |
| Total Equity Gross Minority Interest | 306.5M | 309.8M | 300.0M | 303.4M | 309.9M | -- |
| Total Capitalization | 331.5M | 334.8M | 325.0M | 328.4M | 334.9M | -- |
| Net Tangible Assets | 306.5M | 309.8M | 300.0M | 303.4M | 309.9M | -- |
| Tangible Book Value | 306.5M | 309.8M | 300.0M | 303.4M | 309.9M | -- |
| Working Capital | -36.4M | -35.8M | -44.0M | -33.7M | -28.2M | -- |
| Invested Capital | 371.7M | 373.4M | 356.3M | 361.1M | 370.1M | -- |
| Total Debt | 66.1M | 64.5M | 57.2M | 58.7M | 61.3M | -- |
| Net Debt | 65.2M | 63.5M | 56.2M | 57.7M | 60.2M | -- |
| Share Issued | 131.6M | 129.6M | 127.5M | 125.1M | 124.4M | -- |
| Ordinary Shares Number | 131.6M | 129.6M | 127.5M | 125.1M | 124.4M | -- |
| Capital Lease Obligations | 880,000 | 918,000 | 889,000 | 993,000 | 1.1M | -- |
| Current Capital Lease Obligation | 160,000 | 155,000 | 164,000 | 164,000 | 230,000 | -- |
| Current Provisions | 1.5M | 693,000 | 1.1M | 1.1M | 237,000 | -- |
| Derivative Product Liabilities | 303,000 | 0.00 | 1.3M | 39,000 | -- | -- |
| Dividends Payable | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Financial Assets | -- | 703,000 | -- | 0.00 | 1.4M | 49,000 |
| Hedging Assets Current | 5.1M | 8.0M | 0.00 | 2.6M | 7.7M | -- |
| Line Of Credit | 40.2M | 38.6M | 31.4M | 32.7M | 35.3M | -- |
| Long Term Provisions | 38.6M | 39.1M | 41.1M | 39.6M | 37.0M | -- |
| Non Current Deferred Assets | 19.6M | 18.7M | 21.7M | 20.8M | 19.2M | -- |
| Non Current Deferred Taxes Assets | 19.6M | 18.7M | 21.7M | 20.8M | 19.2M | -- |
| Other Inventories | 324,000 | 445,000 | 486,000 | -- | 788,000 | 1.0M |
| Other Properties | 1.2B | 1.1B | 1.1B | 1.1B | 1.1B | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.5M | 4.3M | 12.8M | 18.5M | 12.4M | -- |
| Cash Flow From Continuing Operating Activities | 17.5M | 4.3M | 12.8M | 18.5M | 12.4M | -- |
| Depreciation Amortization Depletion | 11.4M | 10.2M | 10.0M | 10.1M | 10.2M | -- |
| Stock Based Compensation | 340,000 | 383,000 | 489,000 | 486,000 | 389,000 | -- |
| Deferred Tax | -842,000 | 3.0M | -880,000 | -1.7M | 1.8M | -- |
| Deferred Income Tax | -842,000 | 3.0M | -880,000 | -1.7M | 1.8M | -- |
| Change In Working Capital | 4.6M | -8.1M | 349,000 | 6.0M | 1.7M | -- |
| Other Non Cash Items | 809,000 | 158,000 | 281,000 | 769,000 | 546,000 | -- |
| Capital Expenditure | -8.3M | -12.8M | -17.3M | -7.7M | -4.9M | -- |
| Purchase Of PPE | -641,000 | -- | -- | -371,000 | -114,000 | 0.00 |
| Net PPE Purchase And Sale | -641,000 | -- | -- | -371,000 | -114,000 | 0.00 |
| Investing Cash Flow | -17.8M | -10.3M | -10.4M | -12.5M | -8.6M | -- |
| Cash Flow From Continuing Investing Activities | -17.8M | -10.3M | -10.4M | -12.5M | -8.6M | -- |
| Issuance Of Debt | 1.7M | -- | 608,000 | -2.7M | 149,000 | -- |
| Repayment Of Debt | -56,000 | 0.00 | -2.0M | -238,000 | -65,000 | -- |
| Net Issuance Payments Of Debt | 1.7M | 7.2M | -1.4M | -2.9M | 84,000 | -- |
| Repurchase Of Capital Stock | -87,000 | 0.00 | 0.00 | -3,000 | 0.00 | -- |
| Net Common Stock Issuance | -87,000 | 0.00 | 0.00 | -3,000 | 0.00 | -- |
| Common Stock Dividend Paid | -1.1M | -1.1M | -1.1M | -3.2M | -3.7M | -- |
| Common Stock Payments | -87,000 | 0.00 | 0.00 | -3,000 | 0.00 | -- |
| Financing Cash Flow | 267,000 | 5.8M | -2.3M | -6.0M | -3.8M | -- |
| Cash Flow From Continuing Financing Activities | 267,000 | 5.8M | -2.3M | -6.0M | -3.8M | -- |
| Changes In Cash | -21,000 | -141,000 | 113,000 | 28,000 | 1,000 | -- |
| Beginning Cash Position | 40,000 | 181,000 | 68,000 | 40,000 | 39,000 | -- |
| End Cash Position | 19,000 | 40,000 | 181,000 | 68,000 | 40,000 | -- |
| Free Cash Flow | 9.3M | -8.5M | -4.4M | 10.8M | 7.5M | -- |
| Interest Paid Supplemental Data | 1.6M | 1.5M | 1.4M | 1.5M | 1.7M | -- |
| Capital Expenditure Reported | -7.6M | -12.8M | -17.3M | -7.3M | -4.7M | -- |
| Cash Dividends Paid | -1.1M | -1.1M | -1.1M | -3.2M | -3.7M | -- |
| Gain Loss On Investment Securities | 3.9M | -11.8M | 5.7M | 6.5M | -7.7M | -- |
| Long Term Debt Payments | -56,000 | 0.00 | 0.00 | -85,000 | -65,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -44,000 | 0.00 | 0.00 | -6,000 | 90,000 | -- |
| Net Income From Continuing Operations | -2.7M | 10.4M | -3.1M | -4.0M | 5.3M | -- |
| Net Long Term Debt Issuance | -56,000 | 0.00 | 0.00 | -85,000 | -65,000 | -- |
| Net Other Financing Charges | -263,000 | -276,000 | 101,000 | -51,000 | -107,000 | -- |
| Net Other Investing Changes | -9.6M | 2.6M | 6.8M | -4.8M | -3.7M | -- |
| Net Short Term Debt Issuance | 1.7M | 7.2M | -1.4M | -2.8M | 149,000 | -- |
| Operating Gains Losses | 3.9M | -11.8M | 5.7M | 6.5M | -7.6M | -- |
| Proceeds From Stock Option Exercised | 108,000 | 40,000 | 135,000 | 147,000 | 0.00 | -- |
| Sale Of PPE | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Short Term Debt Issuance | 1.7M | -- | 608,000 | -2.7M | 149,000 | -- |
| Short Term Debt Payments | -- | -- | -2.0M | -153,000 | -- | -- |